The company’s Ultreon Software combines imaging techniques with artificial intelligence algorithms to give cardiologists a complete view of patients’ coronary blood vessels for enhanced assistance with various treatment options.
Abbott received clearance to market the device in Europe in April.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.